NCT03530397 2026-05-19A Study to Evaluate MEDI5752 in Subjects With Advanced Solid TumorsMedImmune LLCPhase 1 Active not recruiting400 enrolled
NCT04522323 2025-07-25A Study to Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell CarcinomaMedImmune LLCPhase 1 Active not recruiting67 enrolled